GOAL OF STUDY Determine hepatitis B vaccination rates in the setting - - PowerPoint PPT Presentation

goal of study
SMART_READER_LITE
LIVE PREVIEW

GOAL OF STUDY Determine hepatitis B vaccination rates in the setting - - PowerPoint PPT Presentation


slide-1
SLIDE 1

! "#!$%&& !&#&#%#'(!&)*&#%#'(!&+ #, %- #' "#!$%&& .!(/()-(#%#'(!&+

slide-2
SLIDE 2

Hepatitis B virus infection is highly prevalent in

  • Kenya. It results in acute and chronic hepatitis,

hepatic failure, hepatocellular carcinoma and directly contributes to mortality both in its acute and chronic forms of infection. and chronic forms of infection.

Because of its impact on health globally, efforts

are geared towards prevention of HBV infection, especially in highrisk populations, including HCWs.

slide-3
SLIDE 3

Education and vaccination have been shown to

have the greatest impact on reducing infection rates.

Effective vaccination has been available for

almost two decades now but the vaccine is still almost two decades now but the vaccine is still underutilised.

The absence of official government policy on

vaccination of HCWs further compounds the problem of availability of vaccination services.

slide-4
SLIDE 4

Local studies in the public health sector have

demonstrated knowledge deficits with regard to HBV, lack of official facilitation for vaccine provision and poor uptake when voluntary vaccination is offered (45). vaccination is offered (45).

slide-5
SLIDE 5

There is paucity of data on whether an official

HBV vaccination policy and vaccine availability to the HCW in subSaharan Africa has any effect

  • n improving the vaccination rates. This study

attempts to answer these questions and further attempts to answer these questions and further seeks to analyse the factors that determine whether the healthcare workers are vaccinated or not.

Knowledge, attitude and practices, vaccination

rates and determining factors were assessed and

  • analysed. The resulting recommendations shall

be made to the relevant public and private sector authorities

slide-6
SLIDE 6
slide-7
SLIDE 7

STUDY SETTING

The Aga Khan University HospitalNairobi, is a

254 bed notforprofit tertiary hospital

123 HCWs with occupational risk of infection

with hepatitis B virus (HBV). with hepatitis B virus (HBV).

The hospital has a comprehensive HCW

vaccination policy and vaccine available to HCWs as part of medical scheme.

Implementation and monitoring by Staff Health

coordinator and Human Resources department.

slide-8
SLIDE 8

RESEARCH QUESTION

Does hepatitis B vaccination policy and vaccine

provision influence the vaccination rates amongst HCWs in AKUHN? HCWs in AKUHN?

slide-9
SLIDE 9

GOAL OF STUDY

Determine hepatitis B vaccination rates in the setting

  • f a vaccination policy and vaccine availability on the
  • f a vaccination policy and vaccine availability on the

in HCWs

slide-10
SLIDE 10

NULL HYPOTHESIS

Hepatitis B vaccination rates amongst health care

workers are independent of Institutional or personal workers are independent of Institutional or personal factors

slide-11
SLIDE 11

OBJECTIVES

(.45/&(6!

Determine vaccination rate amongst HCWs Determine individual and nonindividual factors that

may influence vaccination /#-.45/&(6!

Determine protective antibody titre levels in vaccinated

HCWs*

Assess knowledge, attitude and practice towards HBV

infection

slide-12
SLIDE 12

METHODS

Cross sectional analytical study Study period January 2011 to May 2011 Computer generated randomised stratified sampling

  • f HCWs in departments
  • f HCWs in departments

Informed consent Inclusion and exclusion criteria applied Questionnaire administered Analysis

slide-13
SLIDE 13
slide-14
SLIDE 14

7 7

Stratified sampling was used due to the

heterogeneity of HCWs

A sample size of 261 allowed us to estimate the

hepatitis B vaccination rate for HCWs at hepatitis B vaccination rate for HCWs at AKUHN with 95% confidence

The estimated rate of Hepatitis B vaccination

was 50% (94) and we hoped to establish this with ±5% error

slide-15
SLIDE 15

n = Z2P(1P) δ2

n = minimum sample size

Z = Z statistic for 95% level of confidence (1.96) P = Estimated Hepatitis B vaccination rate (0.5) δ = Precision with a 95% confidence interval which

7 7

δ = Precision with a 95% confidence interval which gives a margin of error of 0.05.

Substituting for the variables:

n = 1.962 x0.5(10.5) 0.052 n = 384

slide-16
SLIDE 16

Given that this sample sizewas more than 5% of the total

population of HCWs, a finite population correction was done n’ = Z2P(1P) δ2 (N1) + Z2P (1P) n’ = Sample size with finite population correction

7 7

n’ = Sample size with finite population correction N= Population size of interest which is 815 Z = Z statistic for 95% level of confidence (1.96) P = Estimated Hepatitis B vaccination rate (0.5) δ = Precision with a 95% confidence interval which gives a margin of error of 0.05.

n’= 815x1.962 x0.5(10.5)

= 782.726 = 892 0.052(8151)+ 1.962x0.5(10.5) 41.6604

slide-17
SLIDE 17
  • *%!(:899
  • -(!&(4$&(#

;2;<= 319<=

% %

slide-18
SLIDE 18

(($ >($ Age (years) 22 59 33.88 Number of years in position <1 30 7.05

slide-19
SLIDE 19

;?9<= 19<= @A<= 9?<=

(!&(4$&(#4.&,,&(&%

$!! #/&#! 4!&,,

82A<= 22@<=

4!&,, %! ! & !

slide-20
SLIDE 20

23.70% 6.80% 13.50%

(!&(4$&(#4.*&&

  • (/(

$'. & #%#'. )

16.90% 15.80% 8.70% 7.50% 7.10%

) !$%&.)

  • (&(/!

#$!*(' & !

slide-21
SLIDE 21

#B%-'#,*&(&(! !

95.50%

! #

slide-22
SLIDE 22

#$/!#,(,#&(## *&(&(!

  • $/&(#

#%%'$! 87.80% #%%'$! !!-( &

slide-23
SLIDE 23
slide-24
SLIDE 24

REASONS FOR NOT BEING VACCINATED

slide-25
SLIDE 25

There is an association between knowledge of

hepatitis B and vaccination, which is statistically significant (p=0.001)

slide-26
SLIDE 26
  • !"#$$

%&&&

  • !"#$$

!"""

  • !"#$$
  • !"""
  • %&&&

' !()*

  • %&&&

' !()*

  • && +"!"()*!

$$!

slide-27
SLIDE 27

C

  • !"#(""*
slide-28
SLIDE 28
slide-29
SLIDE 29

VACCINATION RATE

Relatively low vaccination rate 39<8= Better than a previous survey conducted in Thika

district, Kenya "281=+Djust comparable to the rate found in HCWs in other developing countries ";AE99=+ rate found in HCWs in other developing countries ";AE99=+

Of note is that in the other studies, the vaccine

was not readily available to the HCWs

It would be expected that in the setting of ready

vaccine availability, the vaccine coverage would be higher

slide-30
SLIDE 30

A comparable setting is the Aga Khan University

Hospital, Karachi, (AKUHK) where 19=of the health care workers are completely immunised

The vaccination policies of the AKUHK and

VACCINATION RATE

The vaccination policies of the AKUHK and

AKUHN are similar, hence the results are directly comparable and one would have expected almost similar results.

slide-31
SLIDE 31

ORGANISATIONAL FACTORS

Vaccination policy implementation HCW vaccination records

? High staff turnover

? High staff turnover

slide-32
SLIDE 32

INDIVIDUAL FACTORS

Staff cadre Attitude

Lack of knowledge

Lack of knowledge

slide-33
SLIDE 33
  • Immediate initiation of vaccination for the

unvaccinated and completion for the partially vaccinated HCWs

Cooperation between the staff health department and

Infection control team to maintain a HCW vaccination schedule and records and offer continuous education schedule and records and offer continuous education

  • n work related risks of infection

Implementation and strengthening of the vaccination

  • policy. This may include inclusion of hepatitis B

education and other health education during

  • rientation programs for new staff.
slide-34
SLIDE 34
  • Mandatory policy for HCWs to be vaccinated

against hepatitis B and to demonstrate protective antibody levels in serum post vaccination

HCW education on the benefits of participation in

research activities as a contribution to the body

  • f scientific knowledge

Public health perspectives

slide-35
SLIDE 35

Vaccination status determination was dependent

  • n honesty of HCW and in the absence of records,

was not verifiable.

Inability to do the serological markers to verify Inability to do the serological markers to verify

immunity post infection or post vaccination

slide-36
SLIDE 36

(!/$!!(#F (!/$!!(#F G$!&(#!H